GL1X · GenesisL1 explorer

MolNFT v1 · #67426 · protein

AP24534, a pan-BCR-abl inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

3IK3: “AP24534, a pan-BCR-abl inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and…”. X-ray diffraction. MolNFT v1 #67426 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3IK3
Type
protein
Length
566 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P00520

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein280—P00520
B—protein286—P00520

Compared structures

  • 3IK3 · AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00520 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase ABL1 (P00520) · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.